![](https://innofocus.com/wp-content/uploads/2023/08/References-Innofocus.jpg)
In certain stages of their growth Innofocus had an active role in companies that have meanwhile exited successfully. A selected number of such ventures :
![](https://innofocus.com/wp-content/uploads/2023/08/S-Biomedic-nv-BE-1.jpg)
S-Biomedic nv (BE)
Skin microbiome therapiesFinancial support from incorporation till exit, R&D tax credit, audit preparation (Baker Tilly), grant applications, financial reporting, budget follow up and due diligence in M&A (JMP Securities USA).
Spin off Johnson & Johnson
Exit: M&A Beiersdorf - Germany
![](https://innofocus.com/wp-content/uploads/2023/08/PharmaFluidics-nv-BE-1.jpg)
PharmaFluidics nv (BE)
Chromatography columns for systems biology and biopharma applicationsCorporate finance, tax incentives, audit preparation (BDO), support in grant management, Series A financial plan and cash runway.
Spin off VUB
Exit M&A Thermo Fischer Scientific - USA
![](https://innofocus.com/wp-content/uploads/2023/08/Asset-21Innofocus.jpg)
Biocartis sa (CH), Biocartis bv (NL) and Biocartis nv (BE)
Molecular diagnostics platformFinancial group structure, ERP Microsoft Dynamics, IFRS implementation (Deloitte), tax optimisation in different countries, Flemish government grants (€5M) and PMV Loan (€10M) for delocalisation to Flanders.
Spin off EPFL (Lausanne)
Exit Euronext
![](https://innofocus.com/wp-content/uploads/2023/08/Biogazelle-nv-BE-1.jpg)
Biogazelle nv (BE)
RNA based assay developmentFinancial management, leasing, sales expansion for Covid testing and government relation management, grant reporting, corporate governance and due diligence for M&A transaction (KPMG).
Spin off Ugent
Exit M&A CellCarta - Canada
![](https://innofocus.com/wp-content/uploads/2023/08/Multiplicom-nv-BE-1.jpg)
Multiplicom nv (BE)
Molecular diagnostic testsFinancial and statutory reporting, EU and Vlaio grant applications, audit preparation (BDO), reduction on withholding tax for researchers and tax due diligence for M&A.
Spin off UAntwerpen – VIB
Exit M&A Agilent - USA
![](https://innofocus.com/wp-content/uploads/2023/08/Movetis-nv-1.jpg)
Movetis nv
Gastro-intestinal: pharmaceutical therapiesLong-term financial planning, Flemish subsidies (€4M), ERP, audit preparations (PWC), ERP, ruling on patent income deduction, IFRS transition, Financial pages in Prospectus (Deloitte), IPO preparation (€100M).
Spin off Janssen Pharmaceutica
Exit Euronext
![](https://innofocus.com/wp-content/uploads/2023/08/Asset-23Innofocus.jpg)
Apitope International nv (BE) and Apitope Technology (Bristol) Ltd (UK)
Immunotherapy for autoimmune diseasesFinancial & HR management, convertible loans and equity funding Series B, IFRS (Moore/EY), preparation Nasdaq listing (BDO/PWC), warrant structure, intercompany transactions and corporate secretary.
Spin off Uhasselt & University of Bristol
Exit M&A Worg Pharmaceuticals - China
![](https://innofocus.com/wp-content/uploads/2023/08/Asset-22Innofocus-1.jpg)
Trinean nv (BE)
Microfluidic optical lab-on-chip systems for biotech and life sciencesExit strategy, 5 Year financial plan, bank relation management, sales reporting, valuation and M&A (Broad Oak Capital Partners USA).
Spin off Ugent – IMEC
Exit M&A Unchained Labs - USA
Innofocus is member of the following professional organizations:
![](https://innofocus.com/wp-content/uploads/2023/08/Asset-17Innofocus-1.jpg)
Flanders Bio
![](https://innofocus.com/wp-content/uploads/2023/08/Asset-18Innofocus-1.jpg)
Institute of Directors – London U.K.
![](https://innofocus.com/wp-content/uploads/2023/08/Asset-20Innofocus.jpg)
BLCC Singapore
![](https://innofocus.com/wp-content/uploads/2023/08/Asset-19Innofocus.jpg)
BHKS (Belgium Hong Kong Society)
Innofocus is regularly assisting companies in their financial application and reporting to the following grant bodies:
![](https://innofocus.com/wp-content/uploads/2023/08/Asset-15Innofocus.jpg)
Funding from Vlaams Agentschap voor Innovatie en Ondernemen
![](https://innofocus.com/wp-content/uploads/2023/08/Asset-16Innofocus.jpg)
Funding from EU
![](https://innofocus.com/wp-content/uploads/2023/08/Asset-14Innofocus-2.jpg)